Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 1883Carcinoma, Non-Small-Cell Lung 1345Prostatic Neoplasms 980Colorectal Neoplasms 848Multiple Myeloma 740Leukemia, Myeloid, Acute 725Neoplasms 689Lung Neoplasms 678Neoplasm Metastasis 642Lymphoma 579Carcinoma, Hepatocellular 571Pancreatic Neoplasms 566Stomach Neoplasms 522Leukemia 511Recurrence 490Leukemia, Lymphocytic, Chronic, B-Cell 459Precursor Cell Lymphoblastic Leukemia-Lymphoma 452Melanoma 450Lymphoma, Non-Hodgkin 442Ovarian Neoplasms 426Lymphoma, Large B-Cell, Diffuse 422Myelodysplastic Syndromes 416Squamous Cell Carcinoma of Head and Neck 415Head and Neck Neoplasms 402Brain Neoplasms 402Rectal Neoplasms 395Glioblastoma 374Carcinoma, Renal Cell 349Hodgkin Disease 338Lymphoma, Follicular 336

Interventions

Surgical Procedures, Operative 1Radiosurgery 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Prostate CA × Clear all
NCT06835725 2026-04-29

ADAPT-25

British Columbia Cancer Agency

Phase 2 Recruiting
100 enrolled
Genitourinary

Prostate CA

NCT06834321 2025-09-08

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

Zhongda Hospital

Phase 2 Recruiting
96 enrolled
Genitourinary

Prostate CA

Data powered by HemOnc (CC BY 4.0) Colophon âš¡